Whole-body 18-F-FDG-PET in patients with leptomeningeal disease and correlation with MRI.

OBJECTIVE Studies evaluating leptomeningeal disease on whole-body 18F-FDG PET are lacking. The purpose was to evaluate PET imaging of leptomeningeal disease and investigate the incremental utility of newer PET reconstructions in leptomeningeal disease. METHODS PET imaging of 56 patients with leptomeningeal disease detected initially on MRI (n = 53) or cytopathology (n = 35) were retrospectively reviewed. Regular 3-dimensional iterative reconstruction (3D IR, n = 56) and advanced reconstruction (AdvRecon, n = 41) PET images were evaluated by readers blinded to clinical and MRI findings for uptake involving cauda equina, posterior fossa and spinal cord. Spinal cord uptake pattern was classified as normal (uptake < liver), uptake = liver, conus uptake > liver, conus and cervical cord uptake > liver and multifocal/diffuse uptake > liver. SUVmax ratios of conus/liver, conus/left atrium and conus/cervical cord were compared between 3D IR and AdvRecon datasets. RESULTS Cauda equina uptake was seen in 64% and 78% on 3D IR and AdvRecon; posterior fossa uptake was seen in 52% and 54% on 3D IR and AdvRecon, respectively. Twelve percent had cauda equina or posterior fossa uptake visible only on AdvRecon. On 3D IR, normal spinal cord uptake was most common (27%); on AdvRecon, conus and cervical cord uptake > liver was most common (32%). Seven of 11 patients with normal spinal cord uptake on 3D IR were upgraded to increased uptake on AdvRecon. AdvRecon showed significantly higher conus/liver, conus/blood pool and conus/cervical cord SUVmax ratios (P < 0.0001). CONCLUSION Abnormal uptake in cauda equina, posterior fossa and spinal cord uptake are visible on FDG PET in leptomeningeal disease with increased conspicuity advanced PET reconstructions.

[1]  H. Temiz,et al.  Physiological fluorodeoxyglucose uptake of spinal cord in adults , 2020, Nuclear medicine communications.

[2]  J. Castelli,et al.  FDG PET in Diffuse Spinal Carcinomatous Meningitis. , 2019, Clinical Nuclear Medicine.

[3]  P. Wen,et al.  The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal. , 2019, Neuro-oncology.

[4]  A. Crombé,et al.  Diffuse cortical hypermetabolism of the cerebellum in meningeal carcinomatosis: Assessment with 18F-FDG-PET/CT and MRI. , 2019, Diagnostic and interventional imaging.

[5]  G. Koca,et al.  Primary Diffuse Leptomeningeal Melanomatosis of Spine: 18F-FDG PET Findings. , 2019, Clinical nuclear medicine.

[6]  G. V. von Schulthess,et al.  Impact of a Bayesian penalized likelihood reconstruction algorithm on image quality in novel digital PET/CT: clinical implications for the assessment of lung tumors , 2018, EJNMMI Physics.

[7]  R. Soffietti,et al.  Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments , 2018, Therapeutic advances in neurological disorders.

[8]  A. Spanu,et al.  Intracranial Leptomeningeal Carcinomatosis: A Diagnostic Study with 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography , 2018, Case Reports in Neurology.

[9]  W. Oyen,et al.  Fever of Unknown Origin: the Value of FDG-PET/CT. , 2017, Seminars in nuclear medicine.

[10]  Mark Lubberink,et al.  Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  H. Ortapamuk,et al.  Intracranial Leptomeningeal Carcinomatosis in Three Cases from Breast Cancer Demonstrated on F-18 Fluorodeoxyglucose Positron Emission Tomography/Computerized Tomography , 2017, Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India.

[12]  I. Niazi,et al.  "Bottle Brush Sign"-Spinal Meningeal Disease on 18F-FDG PET-CT Scan. , 2016, Clinical nuclear medicine.

[13]  D. Renard,et al.  Brain 18F-choline PET/CT in primary diffuse leptomeningeal melanomatosis , 2016, Acta Neurologica Belgica.

[14]  E. Nicolai,et al.  Detection of Leptomeningeal Involvement by 18F-FDG-PET/CT in a Patient With Non-Hodgkin Lymphoma. , 2016, Clinical Nuclear Medicine.

[15]  M. Clemenshaw,et al.  Intracranial Leptomeningeal Carcinomatosis from Breast Cancer Detected on 18F-FDG PET , 2015, The Journal of Nuclear Medicine Technology.

[16]  G. Buyukdereli,et al.  Evaluation of Visible Physiological F-18 FDG Uptake Patterns in Spinal Cord on PET/CT , 2015 .

[17]  Quanshi Wang,et al.  Usefulness of 18F-FDG PET/CT in the detection of neurolymphomatosis , 2014, Nuclear medicine communications.

[18]  R. Andresen,et al.  Leptomeningeal Carcinomatosis with Involvement of the Cerebellar Hemispheres and the Spinal Cord as First Manifestation of a Metastasizing Breast Carcinoma , 2014, Clinical Neuroradiology.

[19]  T. Kaufmann,et al.  Intramedullary Spinal Cord Metastases: Visibility on PET and Correlation with MRI Features , 2014, American Journal of Neuroradiology.

[20]  Vivek Gupta.  Positron emission tomography in spinal cord disease. , 2013, Mayo Clinic proceedings.

[21]  B. O'neill,et al.  [(18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy. , 2013, Mayo Clinic proceedings.

[22]  Koichiro Abe,et al.  Improvement in PET/CT Image Quality with a Combination of Point-Spread Function and Time-of-Flight in Relation to Reconstruction Parameters , 2012, The Journal of Nuclear Medicine.

[23]  A. Bockisch,et al.  Physiological 18F-FDG uptake by the spinal cord: is it a point of consideration for cancer patients? , 2012, Journal of Neuro-Oncology.

[24]  A. Quon,et al.  Pattern of 18F-FDG Uptake in the Spinal Cord in Patients With Non-Central Nervous System Malignancy , 2011, Spine.

[25]  K. Fung,et al.  [18F]Fluorothymidine PET imaging in the diagnosis of leptomeningeal involvement with diffuse large B-cell lymphoma , 2011, Cancer imaging : the official publication of the International Cancer Imaging Society.

[26]  F. Atem,et al.  Visualization of Distal Spinal Cord on F-18 FDG PET/CT , 2009, Clinical nuclear medicine.

[27]  D. Delbeke,et al.  Leptomeningeal Carcinomatosis and Intramedullary Spinal Cord Metastases from Lung Cancer: Detection with FDG Positron Emission Tomography , 2001, Clinical nuclear medicine.

[28]  C. Straathof,et al.  The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis , 1999, Journal of Neurology.

[29]  S. Grossman,et al.  Leptomeningeal carcinomatosis. , 1999, Cancer treatment reviews.

[30]  J. Posner,et al.  Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients , 1982, Cancer.

[31]  I. Namer,et al.  FDG PET in Intracranial Carcinomatous Meningitis. , 2016, Clinical nuclear medicine.

[32]  A. Cagnin,et al.  PET/MRI imaging unmasks leptomeningeal carcinomatosis in unexplained diplopia , 2015, Journal of Neuro-Oncology.

[33]  N. Pavlidis.  The diagnostic and therapeutic management of leptomeningeal carcinomatosis. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.